Skip to the page

Data / Form D filings / OrbitalRx, Inc.

OrbitalRx, Inc.: Form D filings

OrbitalRx, Inc., a technology company in Winston-Salem, NC, filed 10 Form D notices with the SEC between 2018 and 2025. The latest, on October 20, 2025, reports $1.2 million sold of a $2.5 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 SOUTH LIBERTY STREET, Winston-Salem, NC, 27101
Phone
(909) 606-2298
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1740062

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 20, 2025New notice$2,500,000$1,224,329$1,275,67122Aug 26, 2025sec.gov
Mar 5, 2025New notice$1,250,000$958,932$291,06818Jan 6, 2025sec.gov
Oct 9, 2024New notice$1,500,000$1,408,880$91,12018May 26, 2023sec.gov
Aug 9, 2024New notice$1,000,000$855,701$144,29917May 28, 2024sec.gov
Mar 2, 2020Amendment$1,200,000$733,481$466,5197Feb 14, 2020sec.gov
Feb 28, 2020New notice$1,200,000$733,481$466,5197Feb 14, 2020sec.gov
Aug 29, 2019Amendment$2,149,966$2,149,96612Oct 1, 2018sec.gov
Feb 4, 2019Amendment$1,402,736$1,402,73612Oct 1, 2018sec.gov
Oct 5, 2018New notice$1,250,000$718,500$531,5007Oct 1, 2018sec.gov
May 10, 2018New notice$50,000$50,0001May 2, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
JASON S. GASPERExecutive Officer, Director
DAN HACKMANDirector
REN S. ROOMEDirector
ROBERT CRUTCHFIELDDirector
GARY S. ABRAHAMSDirector

Other technology companies in North Carolina that filed recently

Every Form D from the week of Oct 20, 2025 · All recent filings in North Carolina · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what OrbitalRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.